Status:
TERMINATED
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Lead Sponsor:
The Cleveland Clinic
Conditions:
Colorectal Cancer
Diverticular Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The primary objectives of this study are to evaluate the potential for preoperative pharmacogenomics (PGx) testing to positively influence postoperative opioid use through visual analog scale (VAS) gu...
Eligibility Criteria
Inclusion
- Subject capable of giving consent
- Age 18-80
- Scheduled for open colorectal resection at Cleveland Clinic main campus (with preoperative appointment scheduled at least five days before date of surgery)
Exclusion
- Patient does not speak English
- Patient with substance-use disorder (including alcohol)
- Patient diagnosed with major depression
- Patient currently taking opioids
- Previous long-term opioid use (\> 3 months)
- Previous opioid use with a dose of \>100 milligram morphine equivalent (MME)
- Patient has pain-related disorder (e.g. fibromyalgia, sympathetic dystrophy, etc.)
- Documented allergy to pain medication
Key Trial Info
Start Date :
April 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03455751
Start Date
April 17 2018
End Date
January 9 2019
Last Update
March 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195